MedImpact Healthcare Systems, Inc., the nation’s largest independent health solutions, technology, and pharmacy benefit management (PBM) provider, announced today that it has acquired Elixir Solutions, a leading PBM company.
The acquisition is part of MedImpact’s reinvestment strategy and aims to enhance its clinical, technology, health risk management, and consumer empowerment capabilities.
Fred Howe, MedImpact Chairman and CEO, said that the market is looking for an alternative provider that can offer innovative and connected care solutions without compromising on quality, scale, and reliability.
He added that the acquisition is the next step in making care more personal, predictive, portable, and affordable for their clients and members.
MedImpact, which is celebrating its 35th anniversary this year, has been investing in innovation and reinvention to provide an ecosystem of total health and technology solutions for its clients in a complex and challenging healthcare landscape.
The company helps commercial and government health plans improve member health, manage benefits, and reduce drug costs for millions of consumers nationwide.
Howe said that MedImpact is looking forward to further investment and expansion to offer clients an ecosystem of flexible connected health solutions.
MedImpact was advised by BDO USA P.C., DLA Piper, LLP, FTI Consulting, Inc., and UBS Investment Bank for this transaction.